In an interesting study using a mouse model of Ang-II-induced hypertension without smooth muscle ADAM17 participation, caused by gen deletion or systemic pharmacological inhibition of ADAM17, the vascular hypertrophy and perivascular fibrosis were reduced (Takayanagi et al., 2016). This evidence concerns the gene ADAM17 and Hypertension.